The application provides application of a
monascus composition in preparation of a
medicine for preventing and / or treating coronary
microcirculation disorder, wherein the
monascus composition comprises one or more of mulberry
bark, mulberry
branch and
mulberry leaf,
monascus and
pueraria. When the monascus composition is applied in preparation of the
medicine for preventing and / or treating coronary
microcirculation disorder, the following effects can be achieved: 1) improving microvascular structure
abnormality (increasing myocardial microvascular density MVD, reducing perivascular
edema of microvessels, improving lumen
stenosis phenomenon, and good endothelial
cell condition); 2) improving microvascular obstruction (
pathological results show that the content of microvessels is reduced); 3) improving abnormal microvascular
vasomotor function (increasing NO); 4) improving blood
lipid metabolism disorder; and 5) improving heart function (increasing
left ventricular ejection fraction LVEF and left ventricular
short axis shortening rate LVFS, increasing left ventricular
internal pressure maximum rising rate LV+dp / dtmax and left ventricular
internal pressure maximum falling rate LV‑dp / dtmax).